MAPT and Alzheimer disease: Targeting of Tau and α-synuclein by functionalized AuNPs revealed a selective binding of the NPs to misfolded proteins (Tau in AD and α-synuclein in PD), thereby inhibiting their aggregation and toxicity in the tested neuronal cells (Tapia-Arellano, 2024).